Pharmaceutical Research and Manufacturers of America

September 15, 2022

FDA’s drug industry fees are raising concerns about influence

The pharmaceutical industry funds about 75 percent of the agency’s drug division through a controversial program that must be re-approved by Congress by the end of this month. Source link
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more